FSPHX
Price
$26.32
Change
+$1.47 (+5.92%)
Updated
Apr 9 closing price
Net Assets
6.42B
HGHVX
Price
$41.96
Change
+$1.93 (+4.82%)
Updated
Apr 9 closing price
Net Assets
823.93M
Ad is loading...

FSPHX vs HGHVX

Header iconFSPHX vs HGHVX Comparison
Open Charts FSPHX vs HGHVXBanner chart's image
Fidelity Select Health Care
Price$26.32
Change+$1.47 (+5.92%)
VolumeN/A
Net Assets6.42B
Hartford Healthcare R6
Price$41.96
Change+$1.93 (+4.82%)
VolumeN/A
Net Assets823.93M
FSPHX vs HGHVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSPHX vs. HGHVX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPHX is a Hold and HGHVX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.42B vs. HGHVX (824M). HGHVX pays higher dividends than FSPHX: HGHVX (0.46) vs FSPHX (0.02). FSPHX was incepted earlier than HGHVX: FSPHX (44 years) vs HGHVX (6 years). HGHVX (0.91) is less costly to investors than FSPHX (0.65). FSPHX (0) and HGHVX (0) have matching initial minimum investment requirements. HGHVX annual gain was more profitable for investors over the last year : -15.06 vs. FSPHX (-17.51). HGHVX return over 5 years is better than : -1.76 vs. FSPHX (-3.60).
FSPHXHGHVXFSPHX / HGHVX
Total Expense Ratio0.650.9171%
Annual Report Gross Expense Ratio0.650.9171%
Fund Existence44 years6 years-
Gain YTD-8.807-7.786113%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets6.42B824M779%
Annual Yield % from dividends0.020.464%
Returns for 1 year-17.51-15.06116%
Returns for 3 years-16.12-15.04107%
Returns for 5 years-3.60-1.76205%
Returns for 10 years3.99N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BIAFX35.65N/A
N/A
Brown Advisory Flexible Equity Inv
CHTTX17.81N/A
N/A
AMG River Road Mid Cap Value N
MGGPX28.79N/A
N/A
Morgan Stanley Inst Global Opp A
RLUSX14.03N/A
N/A
Lazard US Equity Focus R6
OIEPX21.31N/A
N/A
JPMorgan Equity Income R3